Clinical Trial Update: Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of etanercept and celecoxib for temporomandibular joint disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorder

Drugs mentioned

• CELEBREX (Celecoxib)
• ENBREL (etanercept)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Temporomandibular Joint Disorder | Phase 2 | Status: COMPLETED